<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="15982">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02898818</url>
  </required_header>
  <id_info>
    <org_study_id>T146/2016</org_study_id>
    <nct_id>NCT02898818</nct_id>
  </id_info>
  <brief_title>Vaginal and Oral Microbiome Crosstalk</brief_title>
  <official_title>EMMI - Emättimen Mikrobiomi - Emättimen ja Suun Limakalvojen Vuorovaikutus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the vaginal and oral microbiome by swab samples. On selected cases, also papa smear
      will be studied.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To study the vaginal and oral microbiome by swab samples and on selected groups, by papa
      smear test, to find out the constitution of normal and vaginal microbiome and the cross-talk
      between oral and vaginal mucosa. To find out about the impact of human papilloma virus on
      the microbiome and vice versa.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>microbiome, papa smear</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">520</enrollment>
  <condition>Healthy</condition>
  <condition>Vaginal Discharge</condition>
  <arm_group>
    <arm_group_label>symptomless</arm_group_label>
    <description>vaginal and oral swab sample, questionnaire</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vaginal discharge</arm_group_label>
    <description>vaginal and oral swab sample, questionnaire</description>
  </arm_group>
  <arm_group>
    <arm_group_label>atypical papa smear</arm_group_label>
    <description>vaginal and oral swab sample, questionnaire, papa smear</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no atypical papa smear</arm_group_label>
    <description>vaginal and oral swab sample, questionnaire, papa smear</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lichen planus</arm_group_label>
    <description>vaginal and oral swab sample, questionnaire, papa smear</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>vaginal and oral swab sample, questionnaire</intervention_name>
    <description>vaginal and oral swab sample and questionnaire</description>
    <arm_group_label>symptomless</arm_group_label>
    <arm_group_label>vaginal discharge</arm_group_label>
    <arm_group_label>atypical papa smear</arm_group_label>
    <arm_group_label>no atypical papa smear</arm_group_label>
    <arm_group_label>lichen planus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>papa smear</intervention_name>
    <description>Papnicolaou Papa Smear test</description>
    <arm_group_label>atypical papa smear</arm_group_label>
    <arm_group_label>no atypical papa smear</arm_group_label>
    <arm_group_label>lichen planus</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      swab sample from vaginal ja oral smear, including microbes and epithelial cells
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients coming to Turku University Hospital Dermato-Venereology Department for venereal
        disease tests with or without vaginal discharge. Patients coming to Turku University
        Hospital Gynaecology Department by remission because of atypical papa smear test result or
        (controls) for some other reason
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients coming to Turku University Hospital Dermato-Venereology or Gynaecology
             Departments for previously mentioned reasons

        Exclusion Criteria:

          -  those not meeting the criteria
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Niina K Hieta, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>specialist</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Niina K Hieta, MD, PhD</last_name>
    <phone>2-3131620</phone>
    <phone_ext>+358-</phone_ext>
    <email>niina.hieta@tyks.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katja M Kero, Md, PhD</last_name>
    <phone>2-3130000</phone>
    <phone_ext>+358-</phone_ext>
    <email>katja.kero@tyks.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <zip>20540</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Niina K Hieta, MD, PhD</last_name>
      <phone>2-3131620</phone>
      <phone_ext>+358-</phone_ext>
      <email>niina.hieta@tyks.fi</email>
    </contact>
    <contact_backup>
      <last_name>Katja M Kero, MD, PhD</last_name>
      <phone>2-3130000</phone>
      <phone_ext>+358-</phone_ext>
      <email>katja.kero@tyks.fi</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 7, 2016</lastchanged_date>
  <firstreceived_date>September 7, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vaginal Discharge</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
